HCA Healthcare, Inc. (NYSE:HCA) Shares Purchased by Connor Clark & Lunn Investment Management Ltd.

Connor Clark & Lunn Investment Management Ltd. grew its stake in HCA Healthcare, Inc. (NYSE:HCA) by 117.5% in the fourth quarter, Holdings Channel.com reports. The firm owned 92,495 shares of the company’s stock after acquiring an additional 49,968 shares during the quarter. Connor Clark & Lunn Investment Management Ltd.’s holdings in HCA Healthcare were worth $27,762,000 at the end of the most recent reporting period.

A number of other institutional investors have also recently added to or reduced their stakes in the stock. Whipplewood Advisors LLC purchased a new position in shares of HCA Healthcare during the 4th quarter worth $31,000. Legacy Investment Solutions LLC purchased a new position in HCA Healthcare during the third quarter worth about $39,000. Activest Wealth Management grew its stake in shares of HCA Healthcare by 1,250.0% in the 4th quarter. Activest Wealth Management now owns 135 shares of the company’s stock valued at $40,000 after buying an additional 125 shares during the period. Pinnacle Bancorp Inc. lifted its holdings in HCA Healthcare by 50.0% in the fourth quarter. Pinnacle Bancorp Inc. now owns 150 shares of the company’s stock valued at $45,000 after acquiring an additional 50 shares during the last quarter. Finally, Eastern Bank acquired a new stake in HCA Healthcare during the fourth quarter worth $62,000. Hedge funds and other institutional investors own 62.73% of the company’s stock.

Analysts Set New Price Targets

A number of analysts recently issued reports on the company. Truist Financial cut their price objective on HCA Healthcare from $430.00 to $390.00 and set a “buy” rating for the company in a research report on Monday, January 6th. Barclays reduced their price target on shares of HCA Healthcare from $392.00 to $366.00 and set an “overweight” rating on the stock in a research note on Monday, January 27th. Raymond James downgraded shares of HCA Healthcare from an “outperform” rating to a “market perform” rating in a report on Friday, November 22nd. JPMorgan Chase & Co. restated a “neutral” rating and set a $380.00 price target on shares of HCA Healthcare in a research report on Tuesday, December 17th. Finally, Cantor Fitzgerald reissued an “overweight” rating and set a $405.00 target price on shares of HCA Healthcare in a research note on Monday, January 27th. One investment analyst has rated the stock with a sell rating, three have given a hold rating, thirteen have assigned a buy rating and two have given a strong buy rating to the company. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $385.67.

Insider Transactions at HCA Healthcare

In other HCA Healthcare news, SVP Jennifer Berres sold 9,533 shares of the firm’s stock in a transaction on Friday, February 14th. The shares were sold at an average price of $322.59, for a total transaction of $3,075,250.47. Following the transaction, the senior vice president now directly owns 15,412 shares of the company’s stock, valued at approximately $4,971,757.08. This trade represents a 38.22 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Insiders own 1.60% of the company’s stock.

HCA Healthcare Trading Down 3.1 %

HCA opened at $313.49 on Thursday. The business’s 50-day simple moving average is $318.19 and its 200-day simple moving average is $346.27. The company has a debt-to-equity ratio of 69.07, a quick ratio of 0.97 and a current ratio of 1.08. The company has a market cap of $77.18 billion, a P/E ratio of 14.27, a PEG ratio of 1.10 and a beta of 1.68. HCA Healthcare, Inc. has a one year low of $289.98 and a one year high of $417.14.

HCA Healthcare (NYSE:HCA) last issued its earnings results on Friday, January 24th. The company reported $6.22 earnings per share (EPS) for the quarter, beating the consensus estimate of $6.03 by $0.19. HCA Healthcare had a net margin of 8.16% and a return on equity of 586.47%. During the same period in the previous year, the business posted $5.90 earnings per share. As a group, equities research analysts expect that HCA Healthcare, Inc. will post 24.98 EPS for the current fiscal year.

HCA Healthcare Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Monday, March 31st. Shareholders of record on Monday, March 17th will be paid a $0.72 dividend. The ex-dividend date of this dividend is Monday, March 17th. This represents a $2.88 dividend on an annualized basis and a yield of 0.92%. This is a boost from HCA Healthcare’s previous quarterly dividend of $0.66. HCA Healthcare’s payout ratio is currently 13.11%.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.